A randomized trial comparing 4.8 vs. 2.4 g/day of oral mesalazine for maintenance of remission in ulcerative colitis. [electronic resource]
Producer: 20160812Description: 933-7 p. digitalISSN:- 1878-3562
- Administration, Oral
- Adult
- Aged
- Aged, 80 and over
- Anti-Inflammatory Agents, Non-Steroidal -- administration & dosage
- Biopsy
- Colitis, Ulcerative -- drug therapy
- Colonoscopy
- Female
- Humans
- Maintenance Chemotherapy -- methods
- Male
- Medication Adherence
- Mesalamine -- administration & dosage
- Middle Aged
- Recurrence
- Single-Blind Method
- Treatment Outcome
No physical items for this record
Publication Type: Comparative Study; Journal Article; Randomized Controlled Trial
There are no comments on this title.
Log in to your account to post a comment.